Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Neoplasms that affect the bone marrow. Such neoplasms may arise in the bone marrow (e.g. myeloid leukemias) or may involve the bone marrow as secondary, metastatic tumors (e.g. metastatic carcinomas to the bone marrow).
Biomarker and diagnostic research for bone marrow neoplasm has been reported in the published literature.
1 clinical trial registered. Interventions under study include drug therapy and biologic therapy. Research is primarily sponsored by academic and government institutions.
115 publications have been identified in PubMed for bone marrow neoplasm. Kisho has analyzed 82 by research type. Research spans Review / Meta-Analysis (48%), Basic Science / Preclinical (18%), and Clinical Trial Publication (11%).
Research Type | Count | % of Total |
|---|---|---|
Research summaries | 39 |
Data assembled from 3 of 12 sources · Last updated Sep 19, 2026, 1:53 PM UTC
Laboratory research | 15 | 18% |
Clinical study results | 9 | 11% |
Testing and diagnosis research | 8 | 10% |
Disease patterns and progression | 8 | 10% |
New treatment approaches | 2 | 2% |
Patient case studies | 1 | 1% |
Larsson AE (2026). [PMID: 41531010](https://pubmed.ncbi.nlm.nih.gov/41531010/). *Eur J Haematol*. [Epidemiology / Natural History]
Zhang S (2026). [PMID: 41527493](https://pubmed.ncbi.nlm.nih.gov/41527493/). *Clin Transl Med*. [Basic Science / Preclinical]
Levis MJ (2026). [PMID: 41052406](https://pubmed.ncbi.nlm.nih.gov/41052406/). *Blood Adv*. [Clinical Trial Publication]
Nasr MM (2026). [PMID: 41105683](https://pubmed.ncbi.nlm.nih.gov/41105683/). *Cancer Res*. [Basic Science / Preclinical]
Bernardelli A (2026). [PMID: 41151993](https://pubmed.ncbi.nlm.nih.gov/41151993/). *Eur J Haematol*. [Review / Meta-Analysis]
Ellis MH (2026). [PMID: 41902804](https://pubmed.ncbi.nlm.nih.gov/41902804/). *Mayo Clin Proc*. [Review / Meta-Analysis]
Kumar S (2025). [PMID: 40406774](https://pubmed.ncbi.nlm.nih.gov/40406774/). *Cureus*. [Epidemiology / Natural History]
Li X (2025). [PMID: 40563403](https://pubmed.ncbi.nlm.nih.gov/40563403/). *Biomolecules*. [Review / Meta-Analysis]
Zhou L (2025). [PMID: 41091148](https://pubmed.ncbi.nlm.nih.gov/41091148/). *J Exp Med*. [Basic Science / Preclinical]
Li Q (2025). [PMID: 40022602](https://pubmed.ncbi.nlm.nih.gov/40022602/). *FASEB J*. [Review / Meta-Analysis]
AI-curated news mentioning bone marrow neoplasm
Updated Jul 23, 2026
A retrospective analysis from two large university breast cancer centers provides real-world insights into bone marrow carcinomatosis in metastatic breast cancer. This study enhances understanding of the disease's impact and patient outcomes.